Xigris (Drotrecogin alfa) is not an antibiotic but is approved for the specific indication of sepsis because of its anticoagulant properties.
Xigris (Drotrecogin alfa) is a drug approved by the Food and Drug Administration for the reduction of mortality in adult patients with severe sepsis who have a high risk of death. Xigris (Drotrecogin alfa) is placed under the class of serine proteases and it has anticoagulant, anti-thrombotic, anti-inflammatory, and profibrinolytic properties.
Xigris (drotrecogin alfa (activated)) is a recombinant form of human activated protein C. Drotrecogin alfa (activated) is a serine protease with the same amino acid sequence as human plasma-derived activated protein C.
Xigris (drotrecogin alfa) is indicated or used for the reduction of mortality in adult patients with severe sepsis (sepsis associated with acute organ dysfunction) who have a high risk of death.
I know that Lab Safety Rules are important because laboratories have a wide array of safety hazards, which is why it is so important to understand the important of lab safety. By becoming familiar with the laboratory you're working in and always following proper safety procedures, you can help to prevent or eliminate hazards.